Coronavirus vaccine update: Russia says its corona vaccine is ready for use
In a major
breakthrough, the early-stage human trial data has revealed that the coronavirus vaccine candidate developed
by AstraZeneca and Oxford University is safe. German biotech firm BioNTech and
US drugmaker Pfizer also reported that their experimental Covid-19 vaccine was
safe and induced an immune response in patients. The latest developments raise
hope as these could contribute to ending the pandemic, which has infected over
14.7 million people worldwide and claimed over 600,000 lives so far. More than
150 possible vaccines are being developed and tested around the world,
including in India, Britain, China, the US, Russia and Israel to try to stop
the pandemic. At present, 23 vaccine candidates are in human clinical trials.
These include those of Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac,
CanSino Biologics and Inovio Pharmaceuticals.
Coronavirus treatment: Updates on coronavirus vaccine/drug development:
1. Russia claims its coronavirus vaccine is ready for use
A Covid-19 vaccine
developed with the Russian Defense Ministry completed Phase 2 trials, leading
First Deputy Defense Minister Ruslan Tsalikov to say the first domestic
inoculation is ready for use.
Comments
Post a Comment